The effect of empagliflozin on inflammation in patients with overweight or obesity and risk of heart failure: a substudy from the Empire Prevent Metabolic trial
Camilla Andersen, Julie Hempel Larsen, Massar Omar, Nina Nouhravesh et autres
dk (code pays fourni par la source)